Tuesday, April 14, 2026
wellness India Expo
Home Tags Parexel

Tag: Parexel

Parexel announces AI partnership with Weave Bio to accelerate regulatory submission...

Collaboration leverages Parexel's proven regulatory expertise and Weave Bio's AI-native platform, aims to speed up market introduction of new therapies

Jim Anthony appointed as CCO & President of Parexel Biotech

Strategic leadership appointment strengthens company’s commercial approach to drive continued growth and deliver long-term value

Parexel completes CDSCO registration

The registration under the new G.S.R 581(E) regulation reflects Parexel’s commitment to regulatory compliance and clinical research excellence in India

51% of biopharma leaders cite ‘AI expert’ as a top role...

82% of industry senior leaders believe cross-functional roles will increase, with adaptability & agility called out as the most critical skills needed for the workforce of the future

Parexel appoints Charlotte Moser as its Chief Medical Officer

Veteran Oncologist and Clinical Development expert to lead global medical strategy supporting patient-focused drug development and delivery

Parexel names Keri Mattox as Chief Business Officer

Healthcare executive to lead company’s business operations and growth strategy

Parexel expands real-world research capabilities with new leadership

Mike D’Ambrosio appointed as Senior Vice President, Global Head of Real World Research, to enhance evidence-based approaches

Parexel’s greenhouse gas reduction targets achieve SBTi validation

Global clinical research leader receives validation for environmental targets, pledging 42% emission cuts and 100% renewable energy by 2030

Parexel releases 2023 ESG report, targets net-zero by 2050

In 2024, Parexel submitted science-based emission reduction targets for validation with the Science Based Target initiative (SBTi), setting a pathway to achieve net-zero value chain greenhouse gas (GHG) emissions (Scopes 1, 2, and 3) by 2050.

Parexel & Palantir announce multi-year strategic partnership to leverage AI to...

Under the collaboration, Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform (AIP) to further power its clinical data platform